Last reviewed · How we verify

NCT04308993

Percutaneous Endoscopic Biliary Exploration in Complex Biliary Stone Disease

Completed Last updated 16 March 2020
What this trial tests

trial testing percutaneous transhepatic choledochoscopy in Biliary Stones in 15 participants. Completed in 19 August 2019.

Timeline
1 January 1999
Primary endpoint
31 August 2016
19 August 2019

Quick facts

Lead sponsorImam Abdulrahman Bin Faisal University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date1 January 1999
Primary completion31 August 2016
Estimated completion19 August 2019

Drugs / interventions tested

Conditions studied

Sponsor

Imam Abdulrahman Bin Faisal University

Who can join

18 and older, any sex, with Biliary Stones. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with complex biliary stone disease are challenging to treat. The investigator present their experience in using urological interventions to treat challenging biliary stones. Methods: Fifteen patients with biliary calculi underwent 21 interventions using either extracorporeal shock wave lithotripsy (ESWL), percutaneous transhepatic choledochoscopy, percutaneous transcystic choledochoscopy, or a combination of these.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Biliary Stones

Currently open trials in the same condition.

Other Imam Abdulrahman Bin Faisal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04308993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing